| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
31,020 |
23,895 |
$985K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,489 |
9,537 |
$422K |
| S8301 |
Infection control supplies, not otherwise specified |
11,105 |
9,671 |
$361K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
8,713 |
7,887 |
$332K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,391 |
2,273 |
$174K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,434 |
2,347 |
$174K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12,565 |
5,733 |
$158K |
| 99444 |
|
2,771 |
863 |
$151K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,037 |
1,924 |
$150K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,755 |
1,662 |
$118K |
| 99442 |
|
5,750 |
2,392 |
$102K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,624 |
2,318 |
$101K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
847 |
768 |
$69K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,421 |
3,806 |
$64K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,239 |
1,092 |
$51K |
| 99350 |
Prolong home eval add 15m |
1,969 |
1,243 |
$49K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
885 |
825 |
$47K |
| 99091 |
|
545 |
390 |
$41K |
| 99000 |
|
4,307 |
3,917 |
$38K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,950 |
2,741 |
$35K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,538 |
2,392 |
$32K |
| 99422 |
|
1,883 |
540 |
$32K |
| 99349 |
|
709 |
666 |
$28K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,379 |
1,128 |
$24K |
| 59430 |
|
234 |
204 |
$19K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,423 |
1,782 |
$18K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,437 |
1,739 |
$17K |
| 90688 |
|
3,559 |
3,426 |
$14K |
| 90670 |
|
1,586 |
1,516 |
$14K |
| 90461 |
|
3,437 |
1,471 |
$13K |
| 81003 |
|
6,362 |
4,155 |
$11K |
| 99460 |
|
131 |
129 |
$9K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
2,326 |
2,150 |
$9K |
| 59514 |
|
13 |
13 |
$9K |
| 99423 |
|
223 |
91 |
$9K |
| 87807 |
|
798 |
751 |
$8K |
| 99381 |
|
125 |
120 |
$8K |
| 90651 |
|
641 |
604 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
107 |
103 |
$6K |
| 82947 |
|
2,589 |
1,989 |
$5K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
89 |
89 |
$5K |
| 86769 |
|
198 |
161 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
83 |
83 |
$5K |
| 90681 |
|
606 |
573 |
$4K |
| 90723 |
|
1,081 |
1,034 |
$4K |
| 76801 |
|
29 |
28 |
$3K |
| 90620 |
|
379 |
362 |
$2K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
46 |
25 |
$2K |
| 90715 |
|
192 |
189 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
37 |
36 |
$2K |
| 96160 |
|
3,190 |
2,970 |
$2K |
| 99462 |
|
53 |
40 |
$2K |
| 97169 |
|
40 |
40 |
$1K |
| 90734 |
|
481 |
458 |
$1K |
| 81025 |
|
176 |
172 |
$1K |
| 99215 |
Prolong outpt/office vis |
19 |
16 |
$1K |
| 90648 |
|
1,478 |
1,419 |
$967.15 |
| 99497 |
|
150 |
145 |
$901.83 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
42 |
41 |
$868.94 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
3,926 |
3,787 |
$825.00 |
| 99385 |
|
13 |
13 |
$823.70 |
| 85018 |
|
548 |
506 |
$780.28 |
| 90710 |
|
162 |
157 |
$723.12 |
| 90633 |
|
751 |
720 |
$671.45 |
| 99050 |
|
42 |
41 |
$612.88 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
42 |
42 |
$539.60 |
| 80503 |
|
29 |
28 |
$514.50 |
| 99344 |
|
103 |
103 |
$408.68 |
| 99457 |
|
397 |
352 |
$371.02 |
| 96101 |
|
25 |
23 |
$297.92 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
183 |
168 |
$265.91 |
| 86580 |
|
27 |
27 |
$195.87 |
| 99458 |
|
399 |
353 |
$181.31 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
789 |
693 |
$168.51 |
| 0011A |
|
13 |
13 |
$160.00 |
| 99443 |
|
52 |
52 |
$98.53 |
| 82950 |
|
19 |
18 |
$75.81 |
| 81002 |
|
30 |
29 |
$64.24 |
| 90662 |
|
148 |
145 |
$57.45 |
| A6453 |
Self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard |
246 |
181 |
$20.74 |
| 36415 |
Collection of venous blood by venipuncture |
1,565 |
1,470 |
$20.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
26 |
24 |
$11.95 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
25 |
24 |
$11.19 |
| 80061 |
Lipid panel |
13 |
13 |
$7.66 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
754 |
696 |
$0.01 |
| 2000F |
|
452 |
431 |
$0.01 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
645 |
606 |
$0.01 |
| 3074F |
|
896 |
722 |
$0.00 |
| 0503F |
|
88 |
80 |
$0.00 |
| 1036F |
|
460 |
440 |
$0.00 |
| 3079F |
|
296 |
262 |
$0.00 |
| 3080F |
|
211 |
182 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
157 |
149 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
111 |
110 |
$0.00 |
| 90696 |
|
89 |
86 |
$0.00 |
| 1170F |
|
72 |
71 |
$0.00 |
| 1101F |
|
228 |
222 |
$0.00 |
| 82044 |
|
12 |
12 |
$0.00 |
| 1111F |
|
28 |
26 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
180 |
177 |
$0.00 |
| 99345 |
Prolong home eval add 15m |
49 |
49 |
$0.00 |
| G8599 |
Aspirin or another antiplatelet therapy not used, reason not given |
12 |
12 |
$0.00 |
| 90698 |
|
14 |
13 |
$0.00 |
| 91301 |
|
14 |
13 |
$0.00 |
| 90716 |
|
44 |
42 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
97 |
87 |
$0.00 |
| 0502F |
|
733 |
472 |
$0.00 |
| 99072 |
|
202 |
200 |
$0.00 |
| 3077F |
|
175 |
162 |
$0.00 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
103 |
71 |
$0.00 |
| 80500 |
|
88 |
84 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
378 |
370 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
430 |
403 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
15 |
15 |
$0.00 |
| 3078F |
|
672 |
570 |
$0.00 |
| 3288F |
|
425 |
409 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
35 |
32 |
$0.00 |
| 90707 |
|
42 |
40 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
27 |
25 |
$0.00 |
| 90700 |
|
108 |
99 |
$0.00 |